Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,412,872
+$1,266,242 QoQ
Shares Held
134,020
+9.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#208
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. AZN ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,412,872 | 134,020 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,146,630 | 122,435 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||